<乌鸦传媒>Notable OS Gains with Dual Immunotherapy in Advanced NSCLC Secondary analysis of CheckMate 227 brings more good news for nivolumab-ipilimumab combo Sep 28, 2019
<乌鸦传媒>BCG Vax: A Shot Against Lung Cancer in Native Populations? 60-year follow-up data from a vaccine trial found surprising results Sep 25, 2019
<乌鸦传媒>Post-Immunotherapy SBRT Boosts Outcomes in Advanced NSCLC Increased systemic response rate, disease control rate, and PFS in phase II trial Sep 17, 2019
<乌鸦传媒>Anti-PD-1/L1 for NSCLC Sparks Talk of the 'C' Word Unprecedented survival at 3 and 5 years, but investigators reluctant to say "cure" Sep 10, 2019
<乌鸦传媒>'Dirtier' Drugs Step Aside in RET-Positive NSCLC Over two-thirds of patients respond to selective RET inhibitor Sep 09, 2019
<乌鸦传媒>TMB in Lung Cancer: 'Not Ready for Prime Time' No association between tumor mutational burden and outcomes in three trials Sep 09, 2019
<乌鸦传媒>Small Cancer Risk With Lung Micronodules Supports classifying small nodules as negative scan result Jul 10, 2019
<乌鸦传媒>More Clarity to Steroids' Effect on Anti-PD-1 Therapy Adverse effects driven by palliative indications associated with poor prognosis Jun 27, 2019
<乌鸦传媒>Rheumatologist's Primer on Checkpoint Inhibitors Specialist reviews the landscape of cancer drugs' autoimmune side effects Apr 09, 2019
<乌鸦传媒>Durable Responses With Keytruda in Later-Line SCLC Plus umbralisib in marginal zone lymphoma and a next-generation TRK-targeted agent Apr 04, 2019
<乌鸦传媒>MET Inhibitor Rescues Some Targeted Tx Failures in NSCLC Savolitinib promising in patients with MET-based resistance to EGFR inhibition Apr 01, 2019 video
<乌鸦传媒>CAR T-Cell Therapy Active in Solid Tumors Preliminary data on safety, efficacy in mesothelioma, sarcomas Mar 31, 2019 video
<乌鸦传媒>Aggressive Tx in Oligometastatic NSCLC Tied to Improved OS Histology, intrathoracic disease burden, and bone metastases may predict outcomes Mar 12, 2019
<乌鸦传媒>Liquid Biopsy Matches Tissue for NSCLC Guidance Increased mutation detection rate, faster turnaround time Feb 27, 2019
<乌鸦传媒>Rapid Heart Rate Tied to Higher Mortality in Cancer Patients Unexplained tachycardia linked with threefold increase in risk of death Jan 28, 2019
<乌鸦传媒>Cancer Treatment and Arthritis: A Growing Complaint Will checkpoint inhibitor-related arthritis outstrip RA in frequency? Dec 27, 2018
<乌鸦传媒>Increased Risk of Chemo-Associated AML for Nearly All Solid Cancers Extended beyond 5 years for most types with greater risk seen in young patients Dec 20, 2018
<乌鸦传媒>Immunotherapy Combo Flops in Metastatic NSCLC Durvalumab plus tremelimumab failed to improve survival versus chemotherapy Dec 13, 2018
<乌鸦传媒>Highlights from Molecular Targets Symposiuim Breast cancer gene expression, activity in GI, lung, and limited-mutation tumors Nov 16, 2018
<乌鸦传媒>Group of Blood Pressure Drugs Linked to Lung Cancer 14% higher likelihood in users of ACE inhibitors; causal relationship unproven Oct 25, 2018
<乌鸦传媒>Hippocampus-Sparing Radiation a New Option in Brain Mets Patients Approach preserved cognitive function, but patient prognosis a key consideration Oct 24, 2018
<乌鸦传媒>Aggressive RT, Surgery Doubles OS in NSCLC With Limited Mets If new drug produced such a response it would make "millions," said expert Oct 22, 2018 video
<乌鸦传媒>FDA Rejects Canakinumab in CVD Prevention CANTOS data not enough to expand indication Oct 19, 2018
<乌鸦传媒>SBRT Doubles 5-Year Survival in Oligometastatic Cancers Most patients in phase II trial had up to three metastatic lesions Oct 17, 2018
<乌鸦传媒>Lung Screening Saves Lives, but Who Should Be Screened? Experts debate controversial screening issues in meeting "Smackdown" Oct 11, 2018
<乌鸦传媒>Lung Cancer Screening Rates Fall Short in VA Adherence was 77% among those with negative baseline screens Oct 04, 2018
<乌鸦传媒>More Evidence that Screening Cuts Lung Cancer Deaths Significantly lower risk in men and women Sep 26, 2018
<乌鸦传媒>Newer ALK Inhibitor Tops Standard in NSCLC Significant improvement in PFS with brigatinib after short follow-up Sep 26, 2018
<乌鸦传媒>Anti-PD-L1 Drug Boosts Survival in Stage III NSCLC New standard of care for patients with inoperable disease Sep 26, 2018
<乌鸦传媒>Add-On Keytruda Boosts OS in Advanced Squamous Lung Cancer Benefit seen across all subgroups, PD-L1 expression levels Sep 25, 2018
<乌鸦传媒>No Survival Benefit with Cranial RT for NSCLC Better disease-free survival, fewer brain mets Sep 25, 2018
<乌鸦传媒>Nothing Good for Older Lung Cancer Patients From Add-On Cisplatin Two trials show no survival benefit and more toxicity Jul 26, 2018
<乌鸦传媒>Surveillance Not Resection Called Best For Subsolid Lung Nodules Opacities tied to increase in lung cancers, but never fatal during a decade of follow-up Jul 25, 2018
<乌鸦传媒>Keytruda Alone Bests Chemo in Advanced NSCLC Monotherapy boosts survival in patients with low PD-L1, no EGFR or ALK alterations Jun 04, 2018
<乌鸦传媒>Refusing Lung Cancer Treatment: Class Trumps Race Wide variation in groups at highest risk of turning down treatment May 25, 2018
<乌鸦传媒>Lung Cancer Screening Rates Disappoint Evidence shows benefit for high-risk smokers but few get tested May 17, 2018
<乌鸦传媒>'Unsolved Mysteries' on Display at AACR Large, diverse program reflects rapid pace of advancement Apr 13, 2018
<乌鸦传媒>ACS: E-Cigarettes OK for Smoking Cessation ... with Caveats Short period of dual use OK, if goal is to quit Feb 22, 2018
